Skip to main content

Articles

Rituximab Maintenance Extends Remission in Follicular Lymphoma, but Overall Survival Unaffected

Surveillance Scanning in Transformed Indolent Lymphoma of Limited Clinical Benefit

PI3K Inhibitors Main Focus of Drug Pipeline for Lymphoma

Promise of Genomic Sequencing for Clinical Decision-Making in Hematopoietic Cancers

Multiple Myeloma, Oncology

Myeloma Drug Arsenal Expanding to New Classes

Multiple Myeloma, Oncology

Lenalidomide Maintenance in Transplant-Eligible Myeloma Population Still Debated

Multiple Myeloma, Oncology

FIRST Trial Shows Value for Continued Use of Lenalidomide in Transplant-Ineligible Patients with Newly Diagnosed Myeloma

Leukemia, Oncology

Nilotinib Sustains Deeper Molecular Response versus Imatinib in Patients with Ph+ CML

Novel CAR-T Therapy Topped the News at ASH 2013

Leukemia, Oncology

Novel Anti-CD20 Antibodies Show Promising Results in Unfit Patients with Chronic Lymphocytic Leukemia

Page 158 of 244
Results 1571 - 1580 of 2434